Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diethylcarbamazine (DEC) does not induce nitric oxide (NO) synthesis

T V Rajan1, L D Shultz, S Babu

  • 1Department of Pathology, University of Connecticut Health Center, Farmington 06030-3105, USA.

Experimental Parasitology
|April 30, 1998
PubMed
Summary

Diethylcarbamazine (DEC) does not stimulate nitric oxide (NO) production in immune cells, suggesting its antifilarial effects are not mediated by NO induction. This research clarifies DEC's obscure mechanism of action against lymphatic filariasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indian National Association for the Study of the Liver Position Statements on Prevention, Diagnosis, and Management of Hepatitis B Virus Infection in India.

Journal of clinical and experimental hepatology·2025
Same author

Initial Surgeon Experiences With a Robotic-Assisted Cochlear Implant Electrode Array Insertion System.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

Size and canopy characteristics of community reserves determine primate occupancy in the state of Meghalaya, India, and implications for its conservation.

Folia primatologica; international journal of primatology·2024
Same author

MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA.

Experimental oncology·2023
Same author

MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS.

Experimental oncology·2022
Same author

ECM-transmitted shear stress induces apoptotic cell extrusion in early breast gland development.

Frontiers in cell and developmental biology·2022

Area of Science:

  • Immunology and Parasitology
  • Pharmacology and Drug Mechanisms

Background:

  • Diethylcarbamazine (DEC) has been a primary treatment for lymphatic filariasis for over 50 years.
  • DEC's precise mechanism of action remains largely unknown, despite extensive clinical use.
  • Previous hypotheses suggest DEC may activate host immune responses or platelets, rather than directly affecting the parasite.

Purpose of the Study:

  • To investigate whether Diethylcarbamazine (DEC) stimulates nitric oxide (NO) production.
  • To determine if NO is involved in the host-defense mechanism targeted by DEC.
  • To explore DEC's potential interaction with interferon-gamma and tumor necrosis factor-alpha in NO synthesis.

Main Methods:

  • Murine macrophages and rat endothelial cells were treated with DEC to measure NO synthesis and secretion.

Related Experiment Videos

  • The study assessed the synergistic effects of DEC with interferon-gamma and tumor necrosis factor-alpha on inducible NO synthase (iNOS) induction.
  • Urinary nitrate levels were monitored in DEC-treated rats as an indicator of NO metabolism.

    • Main Results:

    • Diethylcarbamazine (DEC) did not stimulate the production or secretion of nitric oxide (NO) from either murine macrophages or rat endothelial cells.
    • DEC did not enhance NO synthesis when combined with interferon-gamma or tumor necrosis factor-alpha.
    • No significant increase in urinary nitrate output was observed in rats treated with DEC.

    Conclusions:

    • The findings indicate that Diethylcarbamazine (DEC) does not exert its therapeutic effects by inducing host nitric oxide (NO) production.
    • This study provides evidence against a NO-mediated mechanism for DEC's efficacy in treating filarial infections.
    • Further research is needed to elucidate the true mechanism of action for this long-standing antifilarial drug.